Apurinic sites are position-specific topoisomerase II poisons.

Kingma PS, Osheroff N
J Biol Chem. 1997 272 (2): 1148-55

PMID: 8995415 · DOI:10.1074/jbc.272.2.1148

Many anticancer drugs "poison" topoisomerase II by enhancing its double-stranded DNA cleavage activity. To determine whether DNA lesions act as endogenous topoisomerase II poisons, we characterized the effects of position-specific apurinic sites on enzyme activity. Lesions located within the 4-base overhang generated by enzyme-mediated DNA scission stimulated cleavage approximately 10-18-fold without altering the specificity of topoisomerase II. DNA breaks were double-stranded in nature, protein-linked, and readily reversible. In contrast, apurinic sites located immediately outside the cleavage overhang were inhibitory. Thus, apurinic sites, which are the most commonly formed lesion in DNA, are position-specific topoisomerase II poisons. A model is proposed that encompasses the actions of endogenous and exogenous topoisomerase II poisons and provides a pre-existing pathway for the cellular actions of topoisomerase II-targeted anticancer drugs.

MeSH Terms (10)

Animals Apurinic Acid Base Sequence Binding Sites DNA DNA Topoisomerases, Type II Drosophila melanogaster Etoposide Models, Molecular Molecular Sequence Data

Connections (1)

This publication is referenced by other Labnodes entities: